ATE102044T1 - Stabilisiertes fgf-mittel und dessen herstellung. - Google Patents

Stabilisiertes fgf-mittel und dessen herstellung.

Info

Publication number
ATE102044T1
ATE102044T1 AT90112850T AT90112850T ATE102044T1 AT E102044 T1 ATE102044 T1 AT E102044T1 AT 90112850 T AT90112850 T AT 90112850T AT 90112850 T AT90112850 T AT 90112850T AT E102044 T1 ATE102044 T1 AT E102044T1
Authority
AT
Austria
Prior art keywords
fgf protein
stabilized
production
water
stabilized fgf
Prior art date
Application number
AT90112850T
Other languages
English (en)
Inventor
Yohko Akiyama
Minoru Yoshioka
Nobuyuki Kitamori
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE102044T1 publication Critical patent/ATE102044T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1825—Fibroblast growth factor [FGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Fodder In General (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT90112850T 1989-07-07 1990-07-05 Stabilisiertes fgf-mittel und dessen herstellung. ATE102044T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17622889 1989-07-07
JP13633390 1990-05-24
EP90112850A EP0406856B1 (de) 1989-07-07 1990-07-05 Stabilisiertes FGF-Mittel und dessen Herstellung

Publications (1)

Publication Number Publication Date
ATE102044T1 true ATE102044T1 (de) 1994-03-15

Family

ID=26469955

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90112850T ATE102044T1 (de) 1989-07-07 1990-07-05 Stabilisiertes fgf-mittel und dessen herstellung.

Country Status (14)

Country Link
US (1) US5189148A (de)
EP (1) EP0406856B1 (de)
JP (1) JP2536247B2 (de)
CN (1) CN1049106A (de)
AT (1) ATE102044T1 (de)
AU (1) AU632344B2 (de)
CA (1) CA2020654A1 (de)
DE (1) DE69006947T2 (de)
DK (1) DK0406856T3 (de)
ES (1) ES2062206T3 (de)
FI (1) FI903440A0 (de)
HU (1) HU205862B (de)
IE (1) IE902470A1 (de)
NO (1) NO902995L (de)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763394A (en) * 1988-04-15 1998-06-09 Genentech, Inc. Human growth hormone aqueous formulation
US5981485A (en) * 1997-07-14 1999-11-09 Genentech, Inc. Human growth hormone aqueous formulation
US5202311A (en) * 1988-08-19 1993-04-13 Children's Medical Center Corporation Stabilized fgf composition
GB9015824D0 (en) * 1990-07-18 1990-09-05 Erba Carlo Spa Stable pharmaceutical compositions containing a fibroblast growth factor
US5714458A (en) * 1990-07-18 1998-02-03 Farmitalia Carlo Erba S.R.L. Stable pharmaceutical compositions containing a fibroblast growth factor
US5500409A (en) * 1990-10-01 1996-03-19 Thomas Jefferson University Method for inhibiting collagen synthesis by keloid fibroblasts
TW209174B (de) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH06508371A (ja) 1991-06-21 1994-09-22 ユニバーシティー オブ シンシナティ 経口投与できる治療用タンパク質及びその製法
US6613332B1 (en) 1991-06-21 2003-09-02 The University Of Cincinnati Oral administration of therapeutic proteins
DE4121043A1 (de) * 1991-06-26 1993-01-07 Merck Patent Gmbh Knochenersatzmaterial mit fgf
CA2080538A1 (en) * 1991-10-21 1993-04-22 Joseph V. Bondi Lyophilized acidic fibroblast growth factor
CA2080537A1 (en) * 1991-10-21 1993-04-22 David B. Volkin Stabilized topical acidic fibroblast growth factor formulation
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5482929A (en) * 1991-12-26 1996-01-09 Kaken Pharmaceutical Co., Ltd. Composition of stabilized fibroblast growth factor
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5348941A (en) * 1992-04-01 1994-09-20 Merck & Co., Inc. Stabilizers for fibroblast growth factors
SE9201073D0 (sv) * 1992-04-03 1992-04-03 Kabi Pharmacia Ab Protein formulation
DE4242889A1 (de) * 1992-12-18 1994-06-23 Merck Patent Gmbh Hohlendoprothesen mit Knochenwachstumsfördernder Füllung
JP3349535B2 (ja) * 1993-01-12 2002-11-25 フロイント産業株式会社 球形顆粒の製造方法
US5331095A (en) * 1993-04-12 1994-07-19 Scios Nova Inc. Process for purification of basic fibroblast growth factor
JP3639593B2 (ja) * 1993-05-31 2005-04-20 科研製薬株式会社 塩基性線維芽細胞増殖因子含有架橋ゼラチンゲル製剤
TW282403B (de) * 1993-08-26 1996-08-01 Takeda Pharm Industry Co Ltd
EP0943336A1 (de) * 1996-09-04 1999-09-22 Dott Research Laboratory Peptid-enthaltende Wirkstoffzusammensetzungen zur oralen Verabreichung
US6692961B1 (en) * 1996-10-11 2004-02-17 Invitrogen Corporation Defined systems for epithelial cell culture and use thereof
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
AU4912100A (en) * 1999-06-07 2000-12-28 Fibersugar Aps Particulate fibre composition
US20030228288A1 (en) 1999-10-15 2003-12-11 Scarborough Nelson L. Volume maintaining osteoinductive/osteoconductive compositions
SK8562002A3 (en) 1999-12-23 2003-10-07 Pfizer Prod Inc Pharmaceutical compositions providing enhanced drug concentrations
JP4711520B2 (ja) * 2000-03-21 2011-06-29 日本ケミカルリサーチ株式会社 生理活性ペプチド含有粉末
US9387094B2 (en) 2000-07-19 2016-07-12 Warsaw Orthopedic, Inc. Osteoimplant and method of making same
US7323193B2 (en) 2001-12-14 2008-01-29 Osteotech, Inc. Method of making demineralized bone particles
WO2003030956A2 (en) 2001-10-12 2003-04-17 Osteotech, Inc. Improved bone graft
FR2836011B1 (fr) * 2002-02-20 2004-05-14 Goemar Lab Sa Agent pour la stimulation des defenses naturelles des plantes et procede pour sa mise en oeuvre
WO2003082321A1 (fr) * 2002-04-01 2003-10-09 Kaken Pharmaceutical Co., Ltd. Preparation pharmaceutique dentaire visqueuse contenant un facteur de croissance des fibroblastes
JP2007503292A (ja) 2003-06-11 2007-02-22 オステオテック インコーポレーテッド 骨インプラント及びその製造方法
ES2404682T3 (es) 2003-12-11 2013-05-28 Isto Technologies Inc. Sistema de cartílago particulado
US20070128685A1 (en) * 2005-07-01 2007-06-07 Rodolfo Faudoa Methods and compositions for cell culture
US20070004036A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for keratinocyte culture
US20070003541A1 (en) * 2005-07-01 2007-01-04 Rodolfo Faudoa Methods and compositions for therapeutics
EP1916964A4 (de) 2005-08-26 2015-11-04 Zimmer Inc Implantate und verfahren zur behebung, ersetzung und behandlung von gelenkkrankheiten
WO2007056671A1 (en) 2005-11-02 2007-05-18 Osteotech, Inc. Hemostatic bone graft
US20080154233A1 (en) * 2006-12-20 2008-06-26 Zimmer Orthobiologics, Inc. Apparatus for delivering a biocompatible material to a surgical site and method of using same
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
US20090012629A1 (en) * 2007-04-12 2009-01-08 Isto Technologies, Inc. Compositions and methods for tissue repair
CA2742047A1 (en) 2008-10-24 2010-04-29 Warsaw Orthopedic, Inc. Compositions and methods for promoting bone formation
CA2868718C (en) * 2012-03-30 2021-08-10 Ajinomoto Co., Inc. Culture medium for proliferating stem cell, which contains sulfated compound
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
WO2017089016A1 (en) 2015-11-27 2017-06-01 Masarykova Univerzita Thermostable fgf2 polypeptide, use thereof
JP2021138648A (ja) * 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤
EP4183796A1 (de) 2021-11-19 2023-05-24 Enantis s.r.o. Thermostabiles fgf10-polypeptid oder fragment davon, verwendung davon

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4717717A (en) * 1986-11-05 1988-01-05 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
NZ235556A (en) * 1986-11-05 1991-06-25 Ethicon Inc Breast milk substitute containing recombinant human egf
JP2526965B2 (ja) * 1987-02-24 1996-08-21 武田薬品工業株式会社 ムテイン，ｄｎａおよびその用途
NZ226171A (en) * 1987-09-18 1990-06-26 Ethicon Inc Gel formulation containing polypeptide growth factor
NZ226170A (en) * 1987-09-18 1990-07-26 Ethicon Inc Stable freeze-dried pharmaceutical composition containing epidermal growth factor

Also Published As

Publication number Publication date
NO902995L (no) 1991-01-08
EP0406856B1 (de) 1994-03-02
FI903440A0 (fi) 1990-07-06
HUT54895A (en) 1991-04-29
CA2020654A1 (en) 1991-01-08
JPH04128239A (ja) 1992-04-28
ES2062206T3 (es) 1994-12-16
DK0406856T3 (da) 1994-07-04
DE69006947T2 (de) 1994-08-25
IE902470A1 (en) 1991-02-13
AU632344B2 (en) 1992-12-24
HU904116D0 (en) 1990-12-28
EP0406856A2 (de) 1991-01-09
DE69006947D1 (de) 1994-04-07
US5189148A (en) 1993-02-23
HU205862B (en) 1992-07-28
EP0406856A3 (en) 1991-04-10
JP2536247B2 (ja) 1996-09-18
NO902995D0 (no) 1990-07-04
AU5879990A (en) 1991-01-10
CN1049106A (zh) 1991-02-13

Similar Documents

Publication Publication Date Title
ATE102044T1 (de) Stabilisiertes fgf-mittel und dessen herstellung.
EP0406274A4 (en) New, water soluble, antineoplastic derivatives of taxol
ZA907338B (en) Thienylcarboxylates of amino alcohols
DE3877406D1 (de) Benzothiazolinon-derivate, ihre herstellung und pharmazeutische zusammensetzung.
HUT47103A (en) Process for producing 1,4-benzoxazine derivatives and pharmaceutical compositions comprising the same
KR0156686B1 (en) Pharmaceutical composition comprising aryl-substituted rhodanine derivatives
DE59006688D1 (de) Substituierte Aminosäureamid-Derivate, deren Herstellung und Verwendung.
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
DE3886936D1 (de) 2,5,6,7-TETRANOR-4,8-INTER-m-PHENYLEN 2-PGI-DERIVATE, VERFAHREN ZUR HERSTELLUNG UND DEREN VERWENDUNG.
DK379387D0 (da) Optisk rene 1,3-dioxenoner, fremgangsmaade til fremstilling deraf og anvendelse heraf
DE3887212D1 (de) Verfahren zur Herstellung von Derivaten von 6,7-Diazyl-7-desacetylforskolin.
DE3868287D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3862766D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
DE3872337D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
ATE147742T1 (de) 8-alpha-acylamino-ergoline, ihre herstellung und verwendung als arzneimittel
ES8607016A1 (es) Preparado solido de nifedipina
DE3865049D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
ATE112264T1 (de) Verfahren zur herstellung von 2,6-di-t-butyl-4- merkaptophenol.
DE58908775D1 (de) 2-Halogensubstituierte N-Indolylethyl-sulfonsäureamide, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln.
ATE133177T1 (de) 3'-deamino-4'-deoxy-4'-amino-8-fluoranthracycli e und verfahren zu ihrer herstellung
DE3782698D1 (de) 5-fluoruridin-derivat und dessen herstellung.
DE3868104D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
EP0362638A3 (en) Method of preparing symmetrical and unsymmetrical monoacetals of aromatic 1,2-diketones
DE59009879D1 (de) Reaktivfarbstoffe, deren Herstellung und Verwendung.
DE3872161D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee